[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BalaBio Research [@BalaBioResearch](/creator/twitter/BalaBioResearch) on x XXX followers Created: 2025-07-14 20:46:31 UTC $FOLD Hard to believe Amicus isn't an acquisition target at these prices. $SNY $BMRN make sense as possible targets, though BMRN would need to leverage with debt. Unless they terribly botch their launches Amicus really should be an easy XX% to XXX% gain in the coming years XXX engagements  **Related Topics** [debt](/topic/debt) [$sny](/topic/$sny) [acquisition](/topic/acquisition) [$fold](/topic/$fold) [sanofi](/topic/sanofi) [stocks healthcare](/topic/stocks-healthcare) [$bmrn](/topic/$bmrn) [Post Link](https://x.com/BalaBioResearch/status/1944861086592720998)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BalaBio Research @BalaBioResearch on x XXX followers
Created: 2025-07-14 20:46:31 UTC
$FOLD Hard to believe Amicus isn't an acquisition target at these prices. $SNY $BMRN make sense as possible targets, though BMRN would need to leverage with debt. Unless they terribly botch their launches Amicus really should be an easy XX% to XXX% gain in the coming years
XXX engagements
Related Topics debt $sny acquisition $fold sanofi stocks healthcare $bmrn
/post/tweet::1944861086592720998